Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
1,022,530
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
187,040
-
Shares change
-
-40,843
-
Total reported value, excl. options
-
$630,094
-
Value change
-
-$98,524
-
Number of buys
-
7
-
Number of sells
-
6
-
Price
-
$3.37
Institutional Holders of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) as of Q2 2023
As of 30 Jun 2023 Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) had 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 187,040 shares of stock of the company.
Largest 10 holders included AdvisorShares Investments LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, VANGUARD GROUP INC, Tower Research Capital LLC (TRC), ACADIAN ASSET MANAGEMENT LLC, GROUP ONE TRADING, L.P., BANK OF AMERICA CORP /DE/, and NATIONAL BANK OF CANADA /FI/.
This table shows 13 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.